4-amino-N,1-dimethyl-1H-pyrazole-5-carboxamide → 6-Cyclopropyl-3-(pyridin-3-ylamino)-pyrazine-2-carboxylic acid (1-methyl-5-methylcarbamoyl-1H-pyrazol-4-yl)-amide
Reaktionsgleichung
[CH:1]1([C:4]2[N:9]=[C:8]([C:10]([OH:12])=O)[C:7]([NH:13][C:14]3[CH:15]=[N:16][CH:17]=[CH:18][CH:19]=3)=[N:6][CH:5]=2)[CH2:3][CH2:2]1.[CH3:20][NH:21][C:22]([C:24]1[N:25]([CH3:30])[N:26]=[CH:27][C:28]=1[NH2:29])=[O:23]>>[CH3:30][N:25]1[C:24]([C:22](=[O:23])[NH:21][CH3:20])=[C:28]([NH:29][C:10]([C:8]2[C:7]([NH:13][C:14]3[CH:15]=[N:16][CH:17]=[CH:18][CH:19]=3)=[N:6][CH:5]=[C:4]([CH:1]3[CH2:2][CH2:3]3)[N:9]=2)=[O:12])[CH:27]=[N:26]1Komponenten
3
Versuchsvorschrift
The product was obtained starting from 6-cyclopropyl-3-(pyridin-3-ylamino)pyrazine-2-carboxylic acid (30 mg, 0.12 mmol) and 4-amino-2-methyl-2H-pyrazole-3-carboxylic acid methylamide (23 mg, 0.15 mmol) according to the method described in example 64, step 6 as yellow solid (30 mg, 64%).
Aufarbeitung
- customThe product was obtained